CDMO - Avid Bioservices Inc
IEX Last Trade
10.54
0.180 1.708%
Share volume: 526,295
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$10.36
0.18
1.74%
Fundamental analysis
12%
Profitability
5%
Dept financing
17%
Liquidity
19%
Performance
15%
Performance
5 Days
-0.38%
1 Month
3.03%
3 Months
32.58%
6 Months
34.44%
1 Year
-12.17%
2 Year
-37.89%
Key data
Stock price
$10.54
DAY RANGE
N/A - N/A
52 WEEK RANGE
$4.07 - $12.45
52 WEEK CHANGE
-$0.16
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
09/05/2024
Company detail
CEO: Nicholas Green
Region: US
Website: http://avidbio.com/
Employees: 307
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://avidbio.com/
Employees: 307
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.
Recent news